These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9240694)
21. Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines. Jang YH; Jung EJ; Byun YH; Lee KH; Lee EY; Lee YJ; Seong BL Vaccine; 2013 Jul; 31(33):3339-46. PubMed ID: 23742997 [TBL] [Abstract][Full Text] [Related]
22. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses. Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598 [TBL] [Abstract][Full Text] [Related]
24. Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus. Di Mario G; Soprana E; Gubinelli F; Panigada M; Facchini M; Fabiani C; Garulli B; Basileo M; Cassone A; Siccardi A; Donatelli I; Castrucci MR Pathog Glob Health; 2017 Mar; 111(2):69-75. PubMed ID: 28081672 [TBL] [Abstract][Full Text] [Related]
25. Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity. Pérez-Girón JV; Gómez-Medina S; Lüdtke A; Munoz-Fontela C J Vis Exp; 2015 Jun; (100):e52803. PubMed ID: 26168339 [TBL] [Abstract][Full Text] [Related]
26. Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts. Ferko B; Kittel C; Romanova J; Sereinig S; Katinger H; Egorov A J Virol; 2006 Dec; 80(23):11621-7. PubMed ID: 16971432 [TBL] [Abstract][Full Text] [Related]
27. Development of live attenuated Bordetella pertussis strains expressing the universal influenza vaccine candidate M2e. Li R; Lim A; Ow ST; Phoon MC; Locht C; Chow VT; Alonso S Vaccine; 2011 Jul; 29(33):5502-11. PubMed ID: 21624415 [TBL] [Abstract][Full Text] [Related]
28. Development of an Alternative Modified Live Influenza B Virus Vaccine. Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580 [TBL] [Abstract][Full Text] [Related]
29. Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity. Li ZN; Mueller SN; Ye L; Bu Z; Yang C; Ahmed R; Steinhauer DA J Virol; 2005 Aug; 79(15):10003-12. PubMed ID: 16014960 [TBL] [Abstract][Full Text] [Related]
30. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques. Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726 [TBL] [Abstract][Full Text] [Related]
31. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge. Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586 [TBL] [Abstract][Full Text] [Related]
33. [Recombinant viruses of poultry as vector vaccines against fowl plague]. Fuchs W; Veits J; Mettenleiter TC Berl Munch Tierarztl Wochenschr; 2006; 119(3-4):160-6. PubMed ID: 16573206 [TBL] [Abstract][Full Text] [Related]
34. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Li S; Rodrigues M; Rodriguez D; Rodriguez JR; Esteban M; Palese P; Nussenzweig RS; Zavala F Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5214-8. PubMed ID: 7685119 [TBL] [Abstract][Full Text] [Related]
35. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase. Schmeisser F; Adamo JE; Blumberg B; Friedman R; Muller J; Soto J; Weir JP Vaccine; 2012 May; 30(23):3413-22. PubMed ID: 22465746 [TBL] [Abstract][Full Text] [Related]